Amarin Corp plc (NASDAQ: AMRN) announced the encore presentation of findings from a post-hoc analysis examining the effects of icosapent ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE